Cited by 324Coenzyme Q10 studies and effectsLipoproteins and Cardiovascular HealthCholesterol and Lipid Metabolism

The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.

Evidence of Plasma CoQ10‐Lowering Effect by HMG‐CoA Reductase Inhibitors: A Double‐Blind, Placebo‐Controlled Study

Ghirlanda, G., Oradei, A., Manto, A., Lippa, S., Uccioli, L., Caputo, S., Greco, A. V., Littarru, G. P.·1993·The Journal of Clinical Pharmacology

DOI 10.1002/j.1552-4604.1993.tb03948.x

Open this paper in CoChat — free account

Abstract

Inhibitors of HMG‐CoA reductase are new safe and effective cholesterol‐lowering agents. Elevation of alanine‐amino transferase (ALT) and aspartate‐amino transferase (AST) has been described in a few cases and a myopathy with elevation of creatinine kinase (CK) has been reported rarely. The inhibition of HMG‐CoA reductase affects also the biosynthesis of ubiquinone (CoQ10). We studied two groups of five healthy volunteers treated with 20 mg/day of pravastatin (Squibb, Italy) or simvastatin (MSD) for a month. Then we treated 30 hypercholesterolemic patients in a double‐blind controlled study with pravastatin, simvastatin (20 mg/day), or placebo for 3 months. At the beginning, and 3 months thereafter we measured plasma total cholesterol, CoQ10, ALT, AST, CK, and other parameters (urea, creatinine, uric acid, total bilirubin, gamma GT, total protein). Significant changes in the healthy volunteer group were detected for total cholesterol and CoQ10 levels, which underwent about a 40% reduction after the treatment. The same extent of reduction, compared with placebo was measured in hypercholesterolemic patients treated with pravastatin or simvastatin. Our data show that the treatment with HMG‐CoA reductase inhibitors lowers both total cholesterol and CoQ10 plasma levels in normal volunteers and in hypercholesterolemic patients. CoQ10 is essential for the production of energy and also has antioxidative properties. A diminution of CoQ10 availability may be the cause of membrane alteration with consequent cellular damage.

Integrity signals

Registry

Crossref · 10.1002/j.1552-4604.1993.tb03948.x

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
Frick, M. H., Elo, O., Haapa, K., Heinonen, O. P., Heinsalmi, P., Helo, P., Huttunen, J. K., Kaitaniemi, P., Koskinen, P., Manninen, V., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198711123172001 · Cited by 3,881
Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
Goodman, D. S. (1988) · Archives of Internal Medicine · doi:10.1001/archinte.1988.00380010040006 · Cited by 2,458
ML-236A, ML-236B, and ML-236C, new inhibitors of cholesterogensis produced by Penicillium citrinum.
Endo, A., KURODA, M., & Tsujita, Y. (1976) · The Journal of Antibiotics · doi:10.7164/antibiotics.29.1346 · Cited by 954
Ubiquinol-10 is an effective lipid-soluble antioxidant at physiological concentrations.
Frei, B. B., Kim, M. C., & Ames, B. N. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.12.4879 · Cited by 623
Muscle coenzyme Q deficiency in familial mitochondrial encephalomyopathy.
Ogasahara, S., Engel, A. G., Frens, D. B., & Mack, D. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.7.2379 · Cited by 365
Rhabdomyolysis in Patients Receiving Lovastatin after Cardiac Transplantation
East, C., Alivizatos, P. A., Grundy, S. M., Jones, P. H., & Farmer, J. A. (1988) · New England Journal of Medicine · doi:10.1056/nejm198801073180111 · Cited by 291
Effects of an Inhibitor of 3-Hydroxy-3-Methylglutaryl Coenzyme a Reductase on Serum Lipoproteins and Ubiquinone-10 Levels in Patients with Familial Hypercholesterolemia
Mabuchi, H., Haba, T., Tatami, R., Miyamoto, S., Sakai, Y., Wakasugi, T., Watanabe, A., Koizumi, J., & Takeda, R. (1981) · New England Journal of Medicine · doi:10.1056/nejm198108273050902 · Cited by 262
Myolysis and Acute Renal Failure in a Heart-Transplant Recipient Receiving Lovastatin
Norman, D. J., Illingworth, D. R., Munson, J. L., & Hosenpud, J. D. (1988) · New England Journal of Medicine · doi:10.1056/nejm198801073180110 · Cited by 255
Rhabdomyolysis and Renal Injury With Lovastatin Use
Corpier, C. L. (1988) · JAMA · doi:10.1001/jama.260.2.239 · Cited by 236
The participation of coenzyme Q in free radical production and antioxidation
Beyer, R. E. (1990) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(90)90154-b · Cited by 209

Show all 23 references

Research works printed but not linked: 9

Lipid Research Clinics Program, 1984, The lipid research clinics coronary primary prevention trial I. Reduction in incidence of coronary heart disease, JAMA, 25, 31
Stamler J, 1984, Is relationship between serum cholesterol and risk of premature death from coronary heart disease continous and graded, JAMA, 251, 365
Brown MS, 1980, Multivalent feedback regulation of HMG‐CoA reductase, a control mechanism coordinating isoprenoid syntesis and cell growth, J Lipid Res, 319, 24
Crane FL, 1984, Biomedical and Clinical Aspect of Coenzyme Q.
Kobayashi M, 1980, Structural effects of ubiquinones on the mitochondrial inner membrane, J Appl Biochem, 2, 270
Beyer RE, 1987, The function of Coenzyme Q in free radical production and as an antioxidant: a review, Chemica Scripta, 27, 145
Mortensen A, 1986, Biomedical Aspects of Coenzyme Q., 39
Frustaci A, 1986, Biomedical Aspects of Coenzyme Q., 157
Beyer RE, 1990, Highlights in Ubiquinone Research., 191

Sorted by citations

Items 101–200 of 322

The effect of statin treatment on circulating coenzyme Q10 concentrations: an updated meta-analysis of randomized controlled trials
Qu, H., Meng, Y., Chai, H., Liang, F., Zhang, J., Gao, Z.-Y., & Shi, D. (2018) · European journal of medical research · doi:10.1186/s40001-018-0353-6 · Cited by 58
Statins lower plasma and lymphocyte ubiquinol/ubiquinone without affecting other antioxidants and PUFA
Passi, S., Stancato, A., Aleo, E., Dmitrieva, A., & Littarru, G. P. (2003) · BioFactors · doi:10.1002/biof.5520180213 · Cited by 57
Self-citation
Pantethine, a derivative of vitamin B5, favorably alters total, LDL and non-HDL cholesterol in low to moderate cardiovascular risk subjects eligible for statin therapy: a triple-blinded placebo and diet-controlled investigation
Evans, M., Rumberger, J. A., Azumano, I., Napolitano, J. J., Citrolo, D., & Kamiya, T. (2014) · Vascular Health and Risk Management · doi:10.2147/vhrm.s57116 · Cited by 56
Biochemistry of Statins
Egom, E. E. A., & Hafeez, H. (2016) · Advances in clinical chemistry · doi:10.1016/bs.acc.2015.10.005 · Cited by 57
Supplemental Conditionally Essential Nutrients in Cardiovascular Disease Therapy
Kendler, B. S. (2006) · The Journal of Cardiovascular Nursing · doi:10.1097/00005082-200601000-00004 · Cited by 54
Important drug-micronutrient interactions: A selection for clinical practice
Gröber, U., Schmidt, J., & Kisters, K. (2018) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2018.1522613 · Cited by 54
Low serum LDL cholesterol levels and the risk of fever, sepsis, and malignancy.
Shor, R., Wainstein, J., Oz, D., Boaz, M., Matas, Z., Fux, A., & Halabe, A. (2007) · PubMed · Cited by 52
Coenzyme Q10: A therapy for hypertension and statin-induced myalgia?
Wyman, M. J., Leonard, M. C., & Morledge, T. J. (2010) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.77a.09078 · Cited by 52
Antioxidative efficacy of parallel and combined supplementation with coenzyme Q10 and d-α-Tocopherol in mildly hypercholesterolemic subjects: a randomized placebo-controlled clinical study
Kaikkonen, J., Nyyssönen, K., Tomasi, A., Iannone, A., Tuomainen, T., Porkkala-Sarataho, E., & Salonen, J. T. (2000) · Free Radical Research · doi:10.1080/10715760000301501 · Cited by 51
Inhibition of cholesterol biosynthesis by squalene epoxidase inhibitor avoids apoptotic cell death in L6 myoblasts
Matzno, S., Yamauchi, T., Gohda, M., Ishida, N., Katsuura, K., Hanasaki, Y., Tokunaga, T., Itoh, H., & Nakamura, N. (1997) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37182-0 · Cited by 50
Statins and Modulation of Oxidative Stress
Bełtowski, J. (2005) · Toxicology Mechanisms and Methods · doi:10.1080/15376520590918766 · Cited by 49
Enhanced oxidizability of ubiquinol and α‐tocopherol during lovastatin treatment
Palomäki, A., Malminiemi, K., & Metsä‐Ketelä, T. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00609-1 · Cited by 49
Comparison of the relative bioavailability of different coenzyme Q 10 formulations with a novel solubilizate (Solu™ Q10)
Schulz, C., Obermüller-Jevic, U. C., Hasselwander, O., Bernhardt, J. H., & Biesalski, H. K. (2006) · International Journal of Food Sciences and Nutrition · doi:10.1080/09637480601058320 · Cited by 48
Analytical method for ubiquinone-9 and ubiquinone-10 in rat tissues by liquid chromatography/turbo ion spray tandem mass spectrometry with 1-alkylamine as an additive to the mobile phase
Teshima, K., & Kondo, T. (2004) · Analytical Biochemistry · doi:10.1016/j.ab.2004.12.007 · Cited by 46
Protection of rat skeletal muscle fibers by either L-carnitine or coenzyme Q10 against statins toxicity mediated by mitochondrial reactive oxygen generation
Guardia, P. G. L., Alberici, L. C., Ravagnani, F. G., Catharino, R. R., & Vercesi, A. E. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00103 · Cited by 46
Squalene monooxygenase - a target for hypercholesterolemic therapy
Belter, A., Skupińska, M., Giel-Pietraszuk, M., Grabarkiewicz, T., Rychlewski, L., & Barciszewski, J. (2011) · Biological Chemistry · doi:10.1515/bc.2011.195 · Cited by 50
A Neuromuscular Approach to Statin-Related Myotoxicity
Baker, S. K., & Samjoo, I. A. (2008) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100007514 · Cited by 45
Mechanisms of action and effects of the administration of Coenzyme Q10 on metabolic syndrome
Casagrande, D., Waib, P. H., & Jordão Júnior, A. A. (2018) · Journal of Nutrition & Intermediary Metabolism · doi:10.1016/j.jnim.2018.08.002 · Cited by 44
Coenzyme Q10 and Statin Myalgia: What is the Evidence?
Mas, E., & Mori, T. A. (2010) · Current Atherosclerosis Reports · doi:10.1007/s11883-010-0134-3 · Cited by 43
Proximal myopathy: diagnostic approach and initial management
Suresh, E., & Wimalaratna, S. (2013) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2013-131752 · Cited by 44
Plasma ubiquinol/cholesterol ratios in patients with hyperlipidaemia, those with diabetes mellitus and in patients requiring dialysis
McDonnell, M., & Archbold, G. P. R. (1996) · Clinica Chimica Acta · doi:10.1016/0009-8981(96)06357-7 · Cited by 44
Lipid-lowering effects of TAK-475, a squalene synthase inhibitor, in animal models of familial hypercholesterolemia
Amano, Y., Nishimoto, T., Tozawa, R.-I., Ishikawa, E., Imura, Y., & Sugiyama, Y. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01549-8 · Cited by 43
Targeting cellular energy production in neurological disorders
Baker, S. K., & Tarnopolsky, M. A. (2003) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.12.10.1655 · Cited by 43
Pharmacophore generation and atom-based 3D-QSAR of N-iso-propyl pyrrole-based derivatives as HMG-CoA reductase inhibitors
Teli, M. K., & Rajanikant, G. K. (2012) · Organic and Medicinal Chemistry Letters · doi:10.1186/2191-2858-2-25 · Cited by 41
Protective Effects of Coenzyme Q10 on Decreased Oxidative Stress Resistance Induced by Simvastatin
Kettawan, A., Takahashi, T., Kongkachuichai, R., Charoenkiatkul, S., Kishi, T., & Okamoto, T. (2007) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.40.194 · Cited by 41
Statin Therapy and the Expression of Genes that Regulate Calcium Homeostasis and Membrane Repair in Skeletal Muscle
Draeger, A., Sánchez-Freire, V., Monastyrskaya, K., Hoppeler, H. H., Mueller, M., Breil, F., Mohaupt, M. G., & Babiychuk, E. B. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.091140 · Cited by 40
Effect of Coenzyme Q10 on the Incidence of Atrial Fibrillation in Patients with Heart Failure
Zhao, Q., Kebbati, A. H., Zhang, Y., Tang, Y., Okello, E., & Huang, C. (2015) · Journal of Investigative Medicine · doi:10.1097/jim.0000000000000202 · Cited by 40
Oral Nanoparticulate Atorvastatin Calcium is More Efficient and Safe in Comparison to Lipicure® in Treating Hyperlipidemia
Meena, A. K., Ratnam, D. V., Chandraiah, G., Ankola, D. D., Rao, P. R., & Kumar, M. N. V. R. (2008) · Lipids · doi:10.1007/s11745-007-3142-5 · Cited by 40
Aspergillus oryzaeproduces compounds inhibiting cholesterol biosynthesis downstream of dihydrolanosterol
Hajjaj, H., Duboc, P., Fay, L. B., Zbinden, I., Macé, K., & Niederberger, P. (2004) · FEMS Microbiology Letters · doi:10.1016/j.femsle.2004.11.001 · Cited by 40
Preparation and Characterization of Oil in Water Nano-Reservoir Systems for Improved Oral Delivery of Atorvastatin
Mustafa, G., Khan, Z. I., Bansal, T., & Talegaonkar, S. (2009) · Current Nanoscience · doi:10.2174/157341309789377989 · Cited by 39
Pharmabiotics as an Emerging Medication for Metabolic Syndrome and Its Related Diseases
Nguyễn, T. T. B., Jin, Y., & Chung, H. (2017) · Molecules · doi:10.3390/molecules22101795 · Cited by 39
A Randomized Clinical Trial to Assess the Effect of Statins on Skeletal Muscle Function and Performance: Rationale and Study Design
Thompson, P. D., Parker, B. A., Clarkson, P. M., Pescatello, L. S., White, C. M., Grimaldi, A. S., Levine, B. D., Haller, R. G., & Hoffman, E. P. (2010) · Preventive Cardiology · doi:10.1111/j.1751-7141.2009.00063.x · Cited by 37
Considerations for Supplementing with Coenzyme Q 10 During Statin Therapy
Levy, H. B., & Kohlhaas, H. K. (2006) · Annals of Pharmacotherapy · doi:10.1345/aph.1g409 · Cited by 37
Pantethine, a derivative of vitamin B5 used as a nutritional supplement, favorably alters low-density lipoprotein cholesterol metabolism in low– to moderate–cardiovascular risk North American subjects: a triple-blinded placebo and diet-controlled investigation
Rumberger, J. A., Napolitano, J. J., Azumano, I., Kamiya, T., & Evans, M. (2011) · Nutrition Research · doi:10.1016/j.nutres.2011.08.001 · Cited by 37
Coenzyme Q10 in cardiovascular disease with emphasis on heart failure and myocardial ischaemia
Langsjoen, P. H., & Langsjoen, A. M. (1998) · The Asia Pacific Heart Journal · doi:10.1016/s1328-0163(98)90022-7 · Cited by 37
Potential metabolic consequences of statins in sepsis*
Brealey, D. A., Singer, M., & Terblanche, M. (2011) · Critical Care Medicine · doi:10.1097/ccm.0b013e31820eb74f · Cited by 36
Impact of Coenzyme Q-10 on Parameters of Cardiorespiratory Fitness and Muscle Performance in Older Athletes Taking Statins
Deichmann, R. E., Lavie, C. J., & Dornelles, A. C. (2012) · The Physician and Sportsmedicine · doi:10.3810/psm.2012.11.1991 · Cited by 35
Lipid Metabolic Alterations in the ALS–FTD Spectrum of Disorders
Godoy-Corchuelo, J. M., Fernández-Beltrán, L. C., Ali, Z., Gil-Moreno, M. J., López-Carbonero, J. I., Guerrero-Sola, A., Larrad-Sainz, A., Matias-Guiu, J., Matias-Guiu, J. A., Cunningham, T. J., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10051105 · Cited by 35
The Interaction Between Statins and Exercise: Mechanisms and Strategies to Counter the Musculoskeletal Side Effects of This Combination Therapy.
Deichmann, R. E., Lavie, C. J., Asher, T., DiNicolantonio, J. J., O’Keefe, J. H., & Thompson, P. D. (2015) · Europe PMC (PubMed Central) · Cited by 35
Benefits & risks of statin therapy for primary prevention of cardiovascular disease in Asian Indians - a population with the highest risk of premature coronary artery disease & diabetes.
Enas, E. A., Kuruvila, A. T., Khanna, P., Pitchumoni, C. S., & Mohan, V. (2013) · Europe PMC (PubMed Central) · Cited by 34
Other Therapies for Reducing Low-Density Lipoprotein Cholesterol: Medications in Development
Stein, E. A. (2009) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2008.11.011 · Cited by 34
Myopathy Associated With Statins and SGLT2 – A Review of Literature
Gupta, R., Alcantara, R., Popli, T., Mahajan, S., Tariq, U., Dusaj, R., & Malik, A. H. (2020) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2020.100765 · Cited by 32
Coenzyme Q10 Supplementation in Statin Treated Patients: A Double-Blinded Randomized Placebo-Controlled Trial
Dohlmann, T. L., Kuhlman, A. B., Morville, T., Dahl, M., Asping, M., Orlando, P., Silvestri, S., Tiano, L., Helge, J. W., Dela, F., et al. (2022) · Antioxidants · doi:10.3390/antiox11091698 · Cited by 31
Total Synthesis of Epohelmin B and Its Analogues
Fürstner, A., & Korte, A. (2007) · Chemistry - An Asian Journal · doi:10.1002/asia.200700288 · Cited by 31
Drug-Induced Rhabdomyolysis
Larbi, E. (1998) · Annals of Saudi Medicine · doi:10.5144/0256-4947.1998.525 · Cited by 31
Azalanstat (RS-21607), a lanosterol 14α-demethylase inhibitor with cholesterol-lowering activity
Burton, P. M., Swinney, D. C., Heller, R. A., Dunlap, B., Chiou, M., Malonzo, E., Haller, J., Walker, K. A. M., Salari, A., Murakami, S., et al. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00152-p · Cited by 31
Gemfibrozil‐induced decrease in serum ubiquinone and α‐ and γ‐tocopherol levels in men with combined hyperlipidaemia
Åberg, Appelkvist, Bröijersén, Eriksson, Angelin, Hjemdahl, & Dallner (1998) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1998.00262.x · Cited by 30
Effects of simvastatin on blood lipids, vitamin E, coenzyme Q10 levels and left ventricular function in humans
Colquhoun, D. M., Jackson, R. V., Walters, M. M., Hicks, B. J., Goldsmith, J., Young, P. M. M., Strakosch, C. R., & Kostner, K. (2005) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2005.01486.x · Cited by 30
Simvastatin Inhibits Glucose Metabolism and Legumain Activity in Human Myotubes
Smith, R. L., Solberg, R., Jacobsen, L. L., Voreland, A. L., Rustan, A. C., Thoresen, G. H., & Johansen, H. T. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085721 · Cited by 29
Effects of simvastatin on plasma antioxidant status and vitamins in hypercholesterolemic patients
Shin, M., Chung, N., Lee, J. H., Jang, Y., Park, E., Jeon, K.-I., Chung, J. H., & Seo, B.-Y. (2006) · International Journal of Cardiology · doi:10.1016/j.ijcard.2006.03.089 · Cited by 29
Coenzyme Q10 Increases Cholesterol Efflux and Inhibits Atherosclerosis Through MicroRNAs
Allen, R. M., & Vickers, K. C. (2014) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.114.303741 · Cited by 29
Effect of FR194738, a potent inhibitor of squalene epoxidase, on cholesterol metabolism in HepG2 cells
Sawada, M., Matsuo, M., Hagihara, H., Tenda, N., Nagayoshi, A., Okumura, H., Washizuka, K., Seki, J., & Goto, T. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01411-x · Cited by 28
HMG CoA reductase‐inhibitor‐related myopathy and the influence of drug interactions
Huynh, T., Cordato, D. J., Yang, F., Choy, T.-K., Johnstone, K., Bagnall, F., Hitchens, N., & Dunn, R. F. (2002) · Internal Medicine Journal · doi:10.1046/j.1445-5994.2002.00264.x · Cited by 28
The use of statins potentiates the insulin-sensitizing effect of exercise training in obese males with and without Type 2 diabetes
Meex, R. C. R., Phielix, E., Schrauwen‐Hinderling, V. B., Moonen‐Kornips, E., Schaart, G., Schrauwen, P., & Hesselink, M. K. C. (2010) · Clinical Science · doi:10.1042/cs20100153 · Cited by 27
Oxidation Injury in Patients Receiving HMG-CoA Reductase Inhibitors
Sinzinger, H. F., Chehne, F., & Lupattelli, G. (2002) · Drug Safety · doi:10.2165/00002018-200225120-00005 · Cited by 27
Coenzyme Q10 remarkably improves the bio-energetic function of rat liver mitochondria treated with statins
Mohammadi‐Bardbori, A., Najibi, A., Amirzadegan, N., Gharibi, R., Dashti, A., Omidi, M., Saeedi, A., Ghaffarian‐Bahraman, A., & Niknahad, H. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.05.041 · Cited by 26
Determination of coenzyme Q in human plasma.
Kaplan, P., Sebestianová, N., Turiaková, J., & Kučera, I. (1996) · PubMed · Cited by 26
Effect of atorvastatin withdrawal on circulating coenzyme Q10 concentration in patients with hypercholesterolemia
Chu, C., Kou, H., Lee, C. S., Lee, K., Chen, S., Voon, W., Sheu, S., & Lai, W. (2006) · BioFactors · doi:10.1002/biof.5520280304 · Cited by 25
Bioavailability of two different formulations of coenzyme Q10 in healthy subjects.
Wahlqvist, M. L., Wattanapenpaiboon, N., Savige, G. S., & Kannar, D. (1998) · PubMed · Cited by 25
Rhabdomyolysis after Biliopancreatic Diversion with Duodenal Switch
Stroh, C., Hohmann, U., Remmler, K., Urban, H., Meyer, F. P., Lippert, H., & Manger, T. (2005) · Obesity Surgery · doi:10.1381/096089205774512672 · Cited by 25
Effects of coenzyme Q10 supplementation on statin-induced myopathy: a meta-analysis of randomized controlled trials
Wei, H., Xin, X., Zhang, J., Xie, Q., Naveed, M., Kaiyan, C., & Xiao, P. (2021) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-021-02651-x · Cited by 24
Synthesis and biological activity of a novel squalene epoxidase inhibitor, FR194738
Sawada, M., Washizuka, K., & Okumura, H. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2003.11.072 · Cited by 24
HMG-CoA Reductase Inhibitors: Is the Endothelium the Main Target?
Puddu, P., Puddu, G. M., & Muscari, A. (2001) · Cardiology · doi:10.1159/000047336 · Cited by 24
CoQ10 and L-carnitine for statin myalgia?
DiNicolantonio, J. J. (2012) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.12.92 · Cited by 23
Effectiveness and Safety of Dietetic Supplementation of a New Nutraceutical on Lipid Profile and Serum Inflammation Biomarkers in Hypercholesterolemic Patients
Riccioni, G., Gammone, M. A., Currenti, W., & D’Orazio, N. (2018) · Molecules · doi:10.3390/molecules23051168 · Cited by 23
The Quality Control Assessment of Commercially Available Coenzyme Q10-Containing Dietary and Health Supplements in Japan
Kettawan, A., Kunthida, C., Takahashi, T., Kishi, T., Chikazawa, J., Sakata, Y., Yano, E., Watabe, K., Yamamoto, Y., & Okamoto, T. (2007) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.2007017 · Cited by 23
Treatment strategies for management of serum lipids: Lessons learned from lipid metabolism, recent clinical trials, and experience with the HMG CoA reductase inhibitors
Rubenfire, M., COLETTI, A., & Mosca, L. J. (1998) · Progress in Cardiovascular Diseases · doi:10.1016/s0033-0620(98)80007-8 · Cited by 24
Fenofibrate plus simvastatin therapy versus simvastatin plus cholestyramine therapy for familial hypercholesterolaemia
Wierzbicki, A. S., Lumb, P. J., Cheung, J., & Crook, M. A. (1997) · QJM · doi:10.1093/qjmed/90.10.631 · Cited by 23
Intraoperative Rhabdomyolysis in a Patient Receiving Pravastatin, a 3-Hydroxy-3-methylglutaryl Coenzyme A (HMG CoA) Reductase Inhibitor
Rosenberg, A. D., Neuwirth, M. G., Kagen, L. J., Singh, K., Fischer, H. D., & Bernstein, R. L. (1995) · Anesthesia & Analgesia · doi:10.1097/00000539-199511000-00034 · Cited by 23
Coenzyme Q10 in acute influenza
Chase, M., Cocchi, M. N., Liu, X., Andersen, L. W., Holmberg, M. J. J., & Donnino, M. W. (2018) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.12608 · Cited by 22
Do Medications Commonly Prescribed to Patients with Peripheral Arterial Disease Have an Effect on Nutritional Status? A Review of the Literature
Fenton, R., Brook-Barclay, L., Delaney, C. L., Spark, J. I., & Miller, M. (2016) · Annals of Vascular Surgery · doi:10.1016/j.avsg.2015.10.036 · Cited by 22
Role of Coenzyme Q and Superoxide in Vitamin E Cycling
Kagan, V. E., Tyurina, Y. Y., & Witt, E. H. (1998) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-1-4899-1789-8_20 · Cited by 22
Red yeast rice and coenzyme Q10 as safe alternatives to surmount atorvastatin-induced myopathy in hyperlipidemic rats
Elbaset, M. A., Safar, M. M., Mahmoud, S. S., Negm, S. A., & Agha, A. M. (2014) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2013-0430 · Cited by 22
Statins and the risk of Parkinson disease: an update on the controversy
Becker, C., & Meier, C. R. (2009) · Expert Opinion on Drug Safety · doi:10.1517/14740330902859956 · Cited by 21
Impact of Vitamin E supplementation on lipoprotein peroxidation and composition in Type 1 diabetic patients treated with Atorvastatin
Manuel‐y‐Keenoy, B. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.04.005 · Cited by 21
Neither plasma coenzyme Q10 concentration, nor its decline during pravastatin therapy, is linked to recurrent cardiovascular disease events: A prospective case–control study from the LIPID study
Stocker, R., Pollicino, C. A., Gay, C. A., Nestel, P. J., Colquhoun, D., Whiting, M. J., Tonkin, A. M., SULLIVAN, D. R., & Simes, J. R. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.09.004 · Cited by 21
Statins and Oxidative Stress During Atherogenesis
Norata, G. D., Pirillo, A., & Catapano, A. L. (2003) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/01.hjr.0000071772.88247.14 · Cited by 18
The Benefits Outweigh the Risks of Treating Hypercholesterolemia: The Statin Dilemma
Hussain, A., Kaler, J., & Ray, S. D. (2023) · Cureus · doi:10.7759/cureus.33648 · Cited by 20
The Role of Mitochondria in Statin-Induced Myopathy
Bell, G. M., Thoma, A., Hargreaves, I. P., & Lightfoot, A. P. (2024) · Drug Safety · doi:10.1007/s40264-024-01413-9 · Cited by 21
Coenzyme Q10 and Utility in Heart Failure: Just Another Supplement?
Oleck, S. A., & Ventura, H. O. (2016) · Current Heart Failure Reports · doi:10.1007/s11897-016-0296-6 · Cited by 19
Nitrogen-Bisphosphonate Therapy Is Linked to Compromised Coenzyme Q10 and Vitamin E Status in Postmenopausal Women
Kalyan, S., Huebbe, P., Esatbeyoglu, T., Niklowitz, P., Côté, H. C. F., Rimbach, G. H., & Kabelitz, D. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3648 · Cited by 19
Plasma coenzyme Q10 predicts lipid-lowering response to high-dose atorvastatin
Pacanowski, M. A., Frye, R. F., Enogieru, O., Schofield, R. S., & Zineh, I. (2008) · Journal of clinical lipidology · doi:10.1016/j.jacl.2008.05.001 · Cited by 19
Acute administration of red yeast rice ( Monascus purpureus ) depletes tissue coenzyme Q 10 levels in ICR mice
Yang, H.-T., Lin, S., Huang, S., & Chou, H.-J. (2005) · British Journal Of Nutrition · doi:10.1079/bjn20041285 · Cited by 19
Review paper The preventive role of coenzyme Q10 and other antioxidants in injuries caused by oxidative stress
Fehér, J., Németh, E., Nagy, V., & Lengyel, G. (2008) · Archives of Medical Science · Cited by 19
Effects of Lovastatin Therapy on Susceptibility of LDL to Oxidation During α-Tocopherol Supplementation
Palomäki, A., Malminiemi, K., Malminiemi, O., & Solakivi, T. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.6.1541 · Cited by 19
Statin-Associated Polymyositis Following Omeprazole Treatment
Kanth, R., Shah, M. S., & Flores, R. (2013) · Clinical Medicine & Research · doi:10.3121/cmr.2012.1110 · Cited by 18
Recent developments in the treatment of atherosclerosis
Brahmkshatriya, P. S., Jani, M. H., & Chhabria, M. T. (2006) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756360500337634 · Cited by 17
Myopathy in patients taking atorvastatin: A pilot study
Madhu, S., Manoj, K., & Jain, N. (2017) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_79_17 · Cited by 17
Rhabdomyolysis-induced compartment syndrome secondary to atorvastatin and strenuous exercise
Dunphy, L., Morhij, R., & Tucker, S. C. (2017) · BMJ Case Reports · doi:10.1136/bcr-2016-218942 · Cited by 17
The effects of Matricaria chamomilla L.hydroalcoholic extract on atherosclerotic plaques, antioxidant activity, lipid profile and inflammatory indicators in rats
Nargesi, S., Moayeri, A., Ghorbani, A., Seifinejad, Y., & Shirzadpour, E. (2018) · Biomedical Research and Therapy · doi:10.15419/bmrat.v5i10.490 · Cited by 17
Combined statin/coenzyme Q10 as adjunctive treatment of chronic heart failure
Okello, E., Jiang, X., Salim, M., Zhao, Q., & Wang, T. (2009) · Medical Hypotheses · doi:10.1016/j.mehy.2009.03.027 · Cited by 17
Efficacy of alternate-day versus everyday dosing of atorvastatin
Pramanik, S., Das, A., Chakrabarty, M., Bandyopadhyay, S. K., Ghosh, M., & Dalai, C. K. (2012) · Indian Journal of Pharmacology · doi:10.4103/0253-7613.96326 · Cited by 16
Coenzyme Q10 protects against β‐cell toxicity induced by pravastatin treatment of hypercholesterolemia
Lorza‐Gil, E., de Souza, J. C., García‐Arévalo, M., Vettorazzi, J. F., Marques, A. C., Salerno, A. G., Trigo, J. R., & Oliveira, H. C. F. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27932 · Cited by 16
Statin cardiomyopathy? A potential role for Co‐Enzyme Q10 therapy for statin‐induced changes in diastolic LV performance: Description of a clinical protocol
Silver, M. A., Langsjoen, P. H., Szabo, S., Patil, H., & Zelinger, A. B. (2003) · BioFactors · doi:10.1002/biof.5520180214 · Cited by 15
Combination Therapy of Cuban Policosanol (Raydel®, 20 mg) and Intensive Exercise for 12 Weeks Resulted in Improvements in Obesity, Hypertension, and Dyslipidemia without a Decrease in Serum Coenzyme Q10: Enhancement of Lipoproteins Quality and Antioxidant Functionality in Obese Participants
Cho, K., Nam, H.-S., Kim, N.-Y., Lee, M.-S., & Kang, D.-J. (2024) · Pharmaceuticals · doi:10.3390/ph17010132 · Cited by 14
Down-regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase mRNA levels and synthesis in Syrian hamster C100 cells by the oxidosqualene cyclase inhibitor [4′-(6-allyl-ethyl-amino-hexyloxy)-2′-fluoro-phenyl]-(4-bromophenyl)-methanone (Ro 48–8071): comparison to simvastatin
Peffley, D. M., Gayen, A. K., & Morand, O. H. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00083-5 · Cited by 14
Secondary coenzyme Q deficiency in neurological disorders
Guéguen, N., Baris, O. R., Lenaers, G., Reynier, P., & Spinazzi, M. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.01.017 · Cited by 14
Coenzyme Q10 in Heart and Brain Diseases
Fedačko, J. (2011) · The Open Nutraceuticals Journal · doi:10.2174/1876396001104010069 · Cited by 14
CoenzymeQ in cellular redox regulation and clinical heart failure
Yuan, S. S., Schmidt, H. M., Wood, K. C., & Straub, A. C. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.03.011 · Cited by 16
Inhibition of Cholesterol Synthesis Causes Both Hypercholesterolemia and Hypocholesterolemia in Hamsters.
Sawada, M., Matsuo, M., & Seki, J. (2002) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.25.1577 · Cited by 13

Authors: Ghirlanda, G., Oradei, A., Manto, A., Lippa, S., Uccioli, L., Caputo, S., Greco, A. V., & Littarru, G. P.
Affiliations: Università Cattolica del Sacro Cuore (IT)
Corresponding author: Ghirlanda, G.
ORCID: Uccioli, L.
Caputo, S.
Venue: The Journal of Clinical Pharmacology
Publisher: Wiley
Published: 1993-03
Volume: 33
Issue: 3
Pages: 226-229
ISSN: 0021-9754 (ISSN-L)
0091-2700
1552-4604
DOI: 10.1002/j.1552-4604.1993.tb03948.x
OpenAlex: W1964874366
Cited by: 324
References: 23
Citations by year: 2026: 2 · 2025: 2 · 2024: 5 · 2023: 3 · 2022: 2 · 2021: 6 · 2020: 3 · 2019: 5 · 2018: 15 · 2017: 12 · 2016: 17 · 2015: 16 · 2014: 11 · 2013: 8 · 2012: 16
FWCI: 1.55
Type: journal article
Language: en
Open access: closed
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor, 7312 d)
Locations: The Journal of Clinical Pharmacology (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Coenzyme Q10 studies and effects
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
Keywords: statins, coenzyme Q10, pravastatin, simvastatin, hypercholesterolemia, serum cholesterol, statin adverse effects, creatine kinase, liver enzymes, myopathy
MeSH terms: Adult, Cholesterol, Double-Blind Method, Female, Humans, Hypercholesterolemia, Lipids, Lovastatin, Male, Middle Aged, Ubiquinone, Pravastatin, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Simvastatin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Evidence of Plasma CoQ10‐Lowering Effect by HMG‐CoA Reductase Inhibitors: A Double‐Blind, Placebo‐Controlled Study

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks